The Business Times
business-time-50

Biolidics' Covid-19 rapid test kit allowed to be sold in EU

google-preferred-sourceAdd BT as a preferred source
Vivienne Tay

Vivienne Tay

Published Mon, Apr 6, 2020 · 09:50 PM

Singapore

SINGAPORE-BASED cancer diagnos-tics company Biolidics on Monday said its rapid test kit for Covid-19 is allowed for sale in the European Union (EU).

This was after the test kit obtained confirmation for CE marking, a notification process to the relevant authority which allows the company to market and sell the kit in the EU. Having the CE marking confirms the test kit complies with the relevant EU product safety directives.

Biolidics

TRENDING NOW

Handled passively, satellite connectivity becomes a service that the telco distributes, while somebody else sets the economics.

When every phone becomes a satellite phone, what happens to Asia’s telcos?

The deal for the sale of Scotts Square mall, just off Orchard Road, is said to be in the early stages of being worked out, at a price of about S$320 million.

Father-and-son duo Raj Kumar and Kishin in exclusive due diligence to buy Scotts Square

Under the Philippines’ new policy, up to four EV models will be provided with as much as 15 billion pesos each in fiscal support, in the form of tax payment certificates.

Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry

For the roughly 80% of South-east Asian conglomerates that are family-controlled, staging capital against tested validation is critical to survival.

The factors that make South-east Asia’s top conglomerates stand out

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More